CLINICAL TRIALS PROFILE FOR DELATESTRYL
✉ Email this page to a colleague
All Clinical Trials for Delatestryl
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00399165 ↗ | Oral Androgens in Man-4: (Short Title: Oral T-4) | Completed | GlaxoSmithKline | Phase 1/Phase 2 | 2006-11-01 | The protocol was designed to address the hypothesis that oral testosterone enanthate plus dutasteride can suppress the secretion of LH and FSH after four weeks of administration. In addition, we will compare the gonadotropin suppression mediated by a dose of testosterone enanthate (400 mg twice daily) that would be expected to maintain the serum testosterone in the normal range throughout the day, with the same dose (800 mg once daily) administered once daily. This larger once-daily dose is expected to result in a higher peak and lower trough by the end of the dosing interval |
| NCT00399165 ↗ | Oral Androgens in Man-4: (Short Title: Oral T-4) | Completed | University of Washington | Phase 1/Phase 2 | 2006-11-01 | The protocol was designed to address the hypothesis that oral testosterone enanthate plus dutasteride can suppress the secretion of LH and FSH after four weeks of administration. In addition, we will compare the gonadotropin suppression mediated by a dose of testosterone enanthate (400 mg twice daily) that would be expected to maintain the serum testosterone in the normal range throughout the day, with the same dose (800 mg once daily) administered once daily. This larger once-daily dose is expected to result in a higher peak and lower trough by the end of the dosing interval |
| NCT00475501 ↗ | 5-Alpha Reductase and Anabolic Effects of Testosterone | Completed | Endo Pharmaceuticals | Phase 2 | 2007-01-01 | The purpose of this study is to determine whether a higher-than-replacement dose of testosterone and finasteride can be combined to safely increase muscle strength in older men who have a low blood concentration of testosterone. |
| NCT00475501 ↗ | 5-Alpha Reductase and Anabolic Effects of Testosterone | Completed | Merck Sharp & Dohme Corp. | Phase 2 | 2007-01-01 | The purpose of this study is to determine whether a higher-than-replacement dose of testosterone and finasteride can be combined to safely increase muscle strength in older men who have a low blood concentration of testosterone. |
| NCT00475501 ↗ | 5-Alpha Reductase and Anabolic Effects of Testosterone | Completed | VA Office of Research and Development | Phase 2 | 2007-01-01 | The purpose of this study is to determine whether a higher-than-replacement dose of testosterone and finasteride can be combined to safely increase muscle strength in older men who have a low blood concentration of testosterone. |
| NCT00965341 ↗ | Testosterone Replacement for Fatigue in Male Hypogonadic Advanced Cancer Patients | Completed | M.D. Anderson Cancer Center | Phase 3 | 2009-09-01 | The goal of this clinical research study is to learn if and how testosterone replacement therapy may affect fatigue in males with advanced cancer and low testosterone levels. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Delatestryl
Condition Name
Clinical Trial Locations for Delatestryl
Trials by Country
Clinical Trial Progress for Delatestryl
Clinical Trial Phase
Clinical Trial Sponsors for Delatestryl
Sponsor Name
